First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer
Authors
Erika Hamilton (ORCID: https://orcid.org/0000-0002-1911-0336)
Nehal J. Lakhani (ORCID: https://orcid.org/0009-0005-6327-0176)
Daphne Stewart (ORCID: https://orcid.org/0000-0001-9845-8375)
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer
Erika Hamilton, Nehal J. Lakhani, Daphne Stewart, Elliot Offman et al.
Citations
10 citations
Journal
Journal for ImmunoTherapy of Cancer
Topics
Phagocytosis and Immune Regulation
Field-Weighted Citation Impact (FWCI)
7.97
article
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer
Erika Hamilton, Nehal J. Lakhani, Daphne Stewart, Elliot Offman, Linda Van Le, Justin Call, Simon Metenou, Lini Pandite, Jade Huguet, Lauren Dockery, Fatima Rangwala, Guanfang Wang, Debra L. Richardson, Bo Ma
article en
10 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal for ImmunoTherapy of CancerVol. 13(1)
Institutions
University of North Carolina at Chapel Hill (US), Lemuel Shattuck Hospital (US), Sarah Cannon (US), City of Hope (US), South Texas Accelerated Research Therapeutics (US), Start Treatment & Recovery Centers (US), University of Oklahoma (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer — Erika Hamilton, Nehal J. Lakhani, et al. · Journal for ImmunoTherapy of Cancer (2025) | TGRS Research Map | TGRS